USPTO serial 88054545
NOVASORB
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- HUNT, LEE
- Law office
- TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NOVASORB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexander Lazouski
ALEXANDER LAZOUSKI LAZOUSKI IP LLCSUITE 1, 14726 BOWFIN TER.LAKEWOOD RANCH, FL 34202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Collyrium; Eye drops; Ophthalmological preparations; Pharmaceutical preparations for the treatment of cataracts; Pharmaceutical preparations for the treatment of glaucoma; Pharmaceutical preparations for the treatment of ocular hypertension; Ophthalmic ointments for medical use for the treatment of eye diseases and conditions; Pharmaceutical preparations for use in eye injections for the treatment of eye diseases and condition; Pharmaceutical preparations for the treatment of pinguecula; Pharmaceutical preparations for the treatment of chalazion; Pharmaceutical preparations for the treatment of uveitis; Eye drops for the treatment of cornea conjunctiva epithelium disorder; Antibacterial eye drops; Antiallergic eye drops; Pharmaceutical preparations for the treatment of eye diseases and conditions; Reagent paper for medical purposes; Oiled paper for medical purposes; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Gauze for medical use; Capsules for medicines, namely, capsules sold empty for pharmaceuticals and drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Eyepatches for medical purposes; Ear bandages; Menstruation bandages; Menstruation tampons; Sanitary napkins; Sanitary panties; Absorbent cotton, namely, cotton for medical purposes and cotton sticks for medical purposes, antiseptic cotton; Adhesive plasters, namely, adhesive plasters for medical purposes, sticking plasters for medical purposes and medical and surgical plasters; Bandages for dressings; Liquid bandages, namely, antiseptic liquid bandages, liquid bandage sprays and liquid bandages for skin wounds; Breast-nursing pads; Cotton sticks for medical purposes; Incontinence diapers; Diapers, namely, adult diapers, baby diapers; Diaper covers, namely, inserts specially adapted for cloth infant diapers made of microfiber and infant diaper covers of textile; Dietary supplements for humans consumption; Nutritional supplements; Dietetic beverages adapted for medical purposes; Dietetic foods adapted for medical purposes; Beverages for babies, namely, infant formula and meal replacement beverages for babies adapted for medical use; Food for babies; Dietary supplements for animals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 6, 2019 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| May 6, 2019 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| May 3, 2019 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Nov 19, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 14, 2018 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Sep 14, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 2, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 1, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 30, 2018 | NWAP | NEW APPLICATION ENTERED | — |